Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 911-922

  Fan, L ^a,b   Benson, H L ^b   Vittal, R ^b   Mickler, E A ^b   Presson, R ^b   Fisher, A Jo ^b   Cummings, O W ^b   Heidler, K M ^b   Keller, M R ^c   Burlingham, W J ^c   Wilkes, D S ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

IL 17; Lung transplantation; mouse; obliterative bronchiolitis

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; MESSENGER RNA; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; DOWN REGULATION; HISTOPATHOLOGY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; SPLEEN; UPREGULATION;

ANIMALS; BRONCHIOLITIS OBLITERANS; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; INTERLEUKIN-10; INTERLEUKIN-17; LUNG TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955532795     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03482.x     Document Type: Article

References (31)

1. Asimacopoulos PJ, Molokhia FA, Pegg CA, Norman JC,. Lung transplantation in the rat. Transplant Proc 1971; 3: 583-585.
2. Okazaki M, Krupnick AS, Kornfeld CG, et al,. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 2007; 7: 1672-1679. (Pubitemid 46776257)
3. McDyer JF,. Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac Soc 2007; 4: 37-43. (Pubitemid 46067561)
4. Sato M, Keshavjee S, Liu M,. Translational research: Animal models of obliterative bronchiolitis after lung transplantation. Am J Transplant 2009; 9: 1981-1987.
5. Hirt SW, You XM, Moller F, et al,. Development of obliterative bronchiolitis after allogeneic rat lung transplantation: Implication of acute rejection and the time point of treatment. J Heart Lung Transplant 1999; 18: 542-548. (Pubitemid 29289179)
6. Yasufuku K, Heidler KM, Woods KA, et al,. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002; 73: 500-505. (Pubitemid 34193606)
7. Slingsby JH, Hogarth MB, Simpson E, Walport MJ, Morley BJ,. New microsatellite polymorphisms identified between C57BL/6, C57BL/10, and C57BL/KsJ inbred mouse strains. Immunogenetics 1996; 43: 72-75. (Pubitemid 126437402)
8. Burlingham WJ, Love RB, Jankowska-Gan E, et al,. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498-3506. (Pubitemid 350097005)
9. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al,. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 1911-1920.
10. Jungraithmayr WM, Korom S, Hillinger S, Weder W,. A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009; 137: 486-491.
11. Cohen AH,. Masson's trichrome stain in the evaluation of renal biopsies. An appraisal. Am J Clin Pathol 1976; 65: 631-643.
12. Stewart S, Fishbein MC, Snell GI, et al,. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242. (Pubitemid 350256994)
13. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK,. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006; 12: 382-388.
14. Ye P, Rodriguez FH, Kanaly S, et al,. Requirement of interleukin 17 receptor signaling for lung Cxc chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-528.
15. Gelman AE, Li W, Richardson SB, et al,. Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009; 182: 3969-3973.
16. Okazaki M, Gelman AE, Tietjens JR, et al,. Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 2007; 37: 625-630. (Pubitemid 350211632)
17. Allan JS, Wain JC, Schwarze ML, Houser SL, Madsen JC, Sachs DH,. Obliterative bronchiolitis develops in miniature swine transplanted across a minor histocompatibility barrier. Transplant Proc 2001; 33: 358-359. (Pubitemid 32237416)
18. Romaniuk A, Prop J, Petersen AH, Wildevuur CR, Nieuwenhuis P,. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation 1987; 44: 209-214. (Pubitemid 17148074)
19. Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T,. De novo production of K-alpha1 tubulin-specific antibodies: Role in chronic lung allograft rejection. J Immunol 2008; 180: 4487-4494.
20. Husain S, Singh N,. Bronchiolitis obliterans and lung transplantation: Evidence for an infectious etiology. Semin Respir Infect 2002; 17: 310-314. (Pubitemid 35453648)
21. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J,. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998; 17: 1255-1263. (Pubitemid 29013408)
22. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, et al,. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999; 159: 829-833. (Pubitemid 29137781)
23. Fiser SM, Kron IL, Long SM, Kaza AK, Kern JA, Tribble CG,. Influence of graft ischemia time on outcomes following lung transplantation. J Heart Lung Transplant 2001; 20: 206-207.
24. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ,. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report-2000. J Heart Lung Transplant 2000; 19: 909-931.
25. Huang HJ, Yusen RD, Meyers BF, et al,. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant 2008; 8: 2454-2462.
26. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM, 3rd,. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114: 195-202. (Pubitemid 27364208)
27. Dhillon GS, Zamora MR, Roos JE, et al,. Lung transplant airway hypoxia: A diathesis to fibrosis? Am J Respir Crit Care Med 2010 182: 230-236.
28. Yamada Y, Sekine Y, Yoshida S, et al,. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 2009; 183: 237-245.
29. Stammberger U, Murat B, Mathias G, et al,. Prolonged amelioration of acute lung allograft rejection by overexpression of human interleukin-10 under control of a long acting ubiquitin C promoter in rats. J Heart Lung Transplant 2006; 25: 1474-1479. (Pubitemid 44909462)
30. Peron JPS, Yang K, Chen M-L, et al,. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J Neuroimmunol 2010; 227: 10-17.
31. Wilson MS, Madala SK, Ramalingam TR, et al,. Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010; 207: 535-552.